Correlation Between Candel Therapeutics and PaxMedica, Common
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and PaxMedica, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and PaxMedica, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and PaxMedica, Common Stock, you can compare the effects of market volatilities on Candel Therapeutics and PaxMedica, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of PaxMedica, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and PaxMedica, Common.
Diversification Opportunities for Candel Therapeutics and PaxMedica, Common
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Candel and PaxMedica, is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and PaxMedica, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PaxMedica, Common Stock and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with PaxMedica, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PaxMedica, Common Stock has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and PaxMedica, Common go up and down completely randomly.
Pair Corralation between Candel Therapeutics and PaxMedica, Common
If you would invest 776.00 in Candel Therapeutics on September 18, 2024 and sell it today you would lose (160.00) from holding Candel Therapeutics or give up 20.62% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 1.59% |
Values | Daily Returns |
Candel Therapeutics vs. PaxMedica, Common Stock
Performance |
Timeline |
Candel Therapeutics |
PaxMedica, Common Stock |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Candel Therapeutics and PaxMedica, Common Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Candel Therapeutics and PaxMedica, Common
The main advantage of trading using opposite Candel Therapeutics and PaxMedica, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, PaxMedica, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PaxMedica, Common will offset losses from the drop in PaxMedica, Common's long position.Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
PaxMedica, Common vs. Quoin Pharmaceuticals Ltd | PaxMedica, Common vs. Revelation Biosciences | PaxMedica, Common vs. Unicycive Therapeutics | PaxMedica, Common vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |